NERV - Minerva Neurosciences Inc Qarzning balans kapitallashuviga nisbati

Minerva Neurosciences Corp (NERV) kompaniyasining korporativ logotipi

Qarzning kapitalga nisbati Minerva Neurosciences (NERV) moliyaviy barqarorligini namoyish etadi, bunda 0.00 ko'rsatkichi parametr holatini belgilaydi. Roluperidon uchun monopol narx belgilash imkoniyati shizofreniya terapiyasining noyobligi tufayli daromad keltirishi kutilmoqda. Ekspertiza barqarorligi testlarni autsorsing qilish jarayonida olimlarning aksiyalar opsionlari orqali kafolatlanadi. Yakuniy xulosa shuki, strategiya salbiy simptomlar davolashdagi bo'sh nishani egallashga asoslangan.

Minerva Neurosciences (NERV) - Balans qiymatiga qarzlar 04.07.2022dan 27.10.2026gacha

Minerva Neurosciences Inc (NERV) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Minerva Neurosciences|NERV - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Minerva|NERV - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Minerva Neurosciences|NERV - Kompaniyaning xususiy kapitali|Bozor qiymatining balans qiymatiga nisbati minervaneurosciences.com|NERV - Kompaniyaning yakuniy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Minerva Neurosciences|NERV - Uzoq muddatli qarzdorlikning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Minerva Neurosciences Corp|NERV - Kompaniyaning jamlangan qarzi|Balans kapitallashuviga qarzlar Minerva
Kompaniyaning fundamental tahlili:Minerva Neurosciences - NERV
Minerva Neurosciences Corp brendining mahsuloti

Qarzning kitob qiymatidagi kapitalizatsiya koeffitsiyenti qarzga olingan mablag'larning kompaniya kapitaliga nisbatini o'lchaydi. Ushbu metrika moliyaviy leveraj darajasini va majburiyatlar tuzilmasidagi qarz yuklamasi xavfini aks ettiradi. Joriy qarzning kitob qiymatidagi kapitalizatsiya tuzilmasini tahlil qilish orqali investor biznesning pul oqimi bo'shliqlari oldidagi barqarorligini baholaydi. Minerva Neurosciences (NERV) uchun roluperidone bo'yicha FDA qarori kutilayotgan vaqtda ushbu muvozanat juda muhimdir. Kreditlarga bo'lgan bog'liqlikni kamaytirish terapiyaning tijorat ishga tushirilishi uchun moliyaviy buferni ta'minlaydi.

Minerva Neurosciences kimlar bilan raqobatlashadi

Qarzning balans qiymatiga nisbati BIIB (Biogen Inc.)|neurocrine.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Regencell Bioscience Holdings Limited (RGC)|AXSM: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati ACAD|XENE (Xenon Corp) - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati VKTX|Qarzning balans qiymatiga nisbati supernus.com|CPRX (Catalyst Pharmaceuticals, Inc.) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar DNLI (Denali)|HRMY - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Biohaven Corp BHVN|AMLX (Amylyx Pharmaceuticals) - Balans kapitallashuviga qarzlar|TRVI: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Praxis Precision Medicines, Inc. PRAX|Qarzning sof aktivlarga nisbati Anavex|Qarzning balans qiymatiga nisbati CeriBell Corp|Qarzning balans kapitallashuviga nisbati prothena.com|Balans kapitallashuviga qarzlar ALEC|Balans kapitallashuviga qarzlar annexonbio.com ANNX|Qarzning balans qiymatiga nisbati Omeros|Neurogene Inc - Qarzning sof aktivlarga nisbati|AC Immune Corp (ACIU) - Qarzning balans kapitallashuviga nisbati|VYGR - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar NMRA|Balans qiymatiga qarzlar scilexholding.com|TVGN (Tevogen Bio) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar ACOG|Cognition Therapeutics (CGTX) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati IKT (Inhibikase Pharma)|SAVA: Qarzning balans kapitallashuviga nisbati|Assertio Holdings - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati COYA (Coya)|VTGN - Sof aktivlarga qarzlar|OVID (ovidrx.com) - Balans kapitallashuviga qarzlar|Acumen Pharmaceuticals, Inc (ABOS) - Qarzning balans qiymatiga nisbati|CRVO: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar Alterity Therapeutics Ltd|Clene Inc. - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar PEPG (pepgen.com)|JUNS - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Relmada Corp RLMD|ANVS: Balans kapitallashuviga qarzlar|GRCE - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar AIFF|KLTO (Klotho Neurosciences) - Balans qiymatiga qarzlar|NRSN: Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar RVPH|Qarzning balans kapitallashuviga nisbati MetaVia Inc MTVA|Qarzning balans qiymatiga nisbati neuraxis.com (NRXS)|HSDT: Balans kapitallashuviga qarzlar|Passage Bio Inc. - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Neuphoria (NEUP)|Athira Pharma Corp (ATHA) - Qarzning sof aktivlarga nisbati|Addex Therapeutics (ADXN) - Qarzning balans qiymatiga nisbati|ALZN (Alzamend Neuro) - Qarzning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati Cyclerion Therapeutics Inc. (CYCN)|Qarzning balans qiymatiga nisbati Protagenic|Pasithea Therapeutics - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar cortigent.com CRGT|Qarzning balans qiymatiga nisbati ATXI (Avenue Therapeutics)|brainstorm-cell.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Cara Therapeutics (CARA)|CHRO: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati ELYM|ITCI (Intra-Cellular Therapies, Inc.) - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati LBPH|Qarzning balans qiymatiga nisbati marinuspharma.com|NKGN (NKGen Biotech) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar NRBO (NeuroBo Pharmaceuticals Inc)|SAGE - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Synaptogenix, Inc SNPX|TRVN (Trevena, Inc.) - Balans kapitallashuviga qarzlar|VIGL: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Anew Medical WENA|Qarzning sof aktivlarga nisbati Cerevel Therapeutics Inc